U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 4,732 records

Showing results for "secondary".

  1. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/841305/psn-pdf
    January 27, 2023 - That secondary affective lesson in simulation is very relevant for clinical care.

  2. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/33734/psn-pdf
    August 01, 2012 - One of the nice things about working in the nursing home world is the availability of secondary datasets

  3. Infectious Disease Including HIV/AIDS #09 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
    December 01, 2013 - HS723 - Collaborative care model (HITIDES) for treatment of depression secondary to HIV. 2011 Oct … HS723 - Collaborative care model (HITIDES) for treatment of depression secondary to HIV. 2011 Oct … HS723 - Collaborative care model (HITIDES) for treatment of depression secondary to HIV. 2011 Oct … HS723 - Collaborative care model (HITIDES) for treatment of depression secondary to HIV. 2011 Oct … HS723 - Collaborative care model (HITIDES) for treatment of depression secondary to HIV. 2011 Oct

  4. Making Healthcare Safer Practices: 10. Harms Due to Opioids (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/opioids-1.pdf
    March 01, 2020 - due to their focus on tertiary prevention (overdose reversal) versus risk reduction with primary and secondary … Secondary analyses revealed that overdose rates decreased significantly (17% per year) with the dose … . (2019) argued that the results are inconsistent given the differences observed in primary versus secondary … significant decrease in overdose rates within the intervention setting during dose reduction (secondary … behavioral therapy; MAT in form of either injectable naltrexone or buprenorphine/ naloxone Secondary

  5. Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the USPSTF (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/R_cAa3AjFGQ2np_aQnzQGA
    February 11, 2025 - denosumab compared with pla- cebo or no treatment were eligible if most enrolled participants did not have secondary … FRAX without BMD assessment, DXA, VFA, fall risk assessment, and blood chemistry analyses to exclude secondary … in persons with a history of fragility fracture or medical conditions or medications associated with secondary … Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis … Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis.

  6. Supplemental Project To Assess the Transparency of Reporting Requirements for Studies Evaluating the Effectiveness of Treatment Options for Symptoms of Diabetic Peripheral Neuropathy (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
    March 01, 2018 - Description of pre-specified primary outcomes, number of primary outcomes 3 Description of secondary … outcome Analysis Description of the pre-specified statistical analysis plan Results of primary and secondary … None of the studies changed a primary outcome to a secondary outcome. … if ever published, would be unlikely to add to the body of evidence because none of the primary or secondary … Results should consist of demographic and baseline characteristics, primary and secondary outcomes,

  7. Nis 2011 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Core.PDF
    January 01, 2011 - 1.00 0.29 0.45 PAY1 : Primary expected payer (uniform) 8,001,068 22,522 1.00 6.00 2.17 1.21 PAY2 : Secondary … W OTHER O.R.PROC 1,203 0.01% 409: RADIOTHERAPY 509 0.01% 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … Distribution for DRG24 DRG24 Frequency Percent of Total 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 232 0.00% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 2,472 0.03% 467 … 0.11% 40: Multiple myeloma 3,830 0.05% 41: Cancer; other and unspecified primary 1,697 0.02% 42: Secondary

  8. Kid 2009 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Core.PDF
    January 01, 2009 - Maximum Mean Std Dev PAY1 : Primary expected payer (uniform) 3,401,922 5,224 1.00 6.00 2.65 0.87 PAY2 : Secondary … CC 1,910 0.06% 464: SIGNS & SYMPTOMS W/O CC 2,696 0.08% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 16 0.00% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 850 0.02% 467: … 0.15% 40: Multiple myeloma <= 10 *.**% 41: Cancer; other and unspecified primary 1,314 0.04% 42: Secondary … disease) 2,504 0.07% 98: Essential hypertension 671 0.02% 99: Hypertension with complications and secondary

  9. Neds 2017 Ip Maskedstats (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2017_IP_MaskedStats.PDF
    January 01, 2017 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 203 0.00 846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 134 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 300 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC <= 10 *.** 849: RADIOTHERAPY … DIAGNOSIS W MCC 134 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 300 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC <= 10 *.** 849: RADIOTHERAPY

  10. Neds 2019 Core Maskedstats (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2019_Core_MaskedStats.PDF
    January 01, 2019 - 27474.45 10127.16 PAY1 : Primary expected payer (uniform) 33,101,751 45,500 1.00 6.00 2.45 1.22 PAY2 : Secondary

  11. Neds 2021 Core Maskedstats (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2021_Core_MaskedStats.PDF
    January 01, 2021 - 27921.76 9779.37 PAY1 : Primary expected payer (uniform) 30,058,581 40,787 1.00 6.00 2.44 1.21 PAY2 : Secondary

  12. Neds 2022 Core Maskedstats (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2022_Core_MaskedStats.PDF
    January 01, 2022 - 28368.85 9592.62 PAY1 : Primary expected payer (uniform) 32,262,843 35,277 1.00 6.00 2.39 1.18 PAY2 : Secondary

  13. Neds 2020 Core Maskedstats (pdf file)

    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2020_Core_MaskedStats.PDF
    January 01, 2020 - 27985.78 9823.26 PAY1 : Primary expected payer (uniform) 27,988,930 48,104 1.00 6.00 2.46 1.23 PAY2 : Secondary

  14. Spotlight (pdf file)

    psnet.ahrq.gov/sites/default/files/2020-05/final_may-spotlight-fatal_pca_slides_05.01.2020_cme_review-revised.pdf
    January 01, 2020 - Avoiding Adverse Events Secondary to Opioid-Induced Respiratory Depression: Implications for Nurse Executives

  15. Enzyme Replacement Therapy for Lysosomal Storage Disorders | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies/research-protocol

  16. Barriers Associated with Medication Information Handoffs (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol3/Bayley.pdf
    January 01, 2004 - Advances in Patient Safety: Vol. 3 96 understand whether a medication list is out-of-date or a secondary … The primary and secondary care interface: the educational needs of nursing staff for the provision

  17. Organizational Climate of Staff Working Conditions and Safety—An Integrative Mode (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Stone.pdf
    January 01, 2004 - variation in the means used by the investigative teams to conduct their regressions, due to the nature of secondary … Finally, two scales constructed in these secondary analyses had lower Cronbach’s alphas than often considered

  18. Summary of Recommendations from Cognitive Testing of the Spanish Translation of the MEPS Cancer SAQ

    meps.ahrq.gov/survey_comp/hc_survey/2011/MEPS_Spanish_Translation_CI_to_Workgroup.shtml
    January 01, 2011 - For most in this group, " secuelas " seemed to work better than " efectos secundarios " (secondary … it may be worth including an alternate term with " secuelas ," such as " efectos secundarios " (secondary

  19. Archived: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-type-2-in-adults-screening-2008
    June 15, 2008 - Several secondary prevention trials of treatments for people with lipid abnormalities reported that lipid … Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density

  20. Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/vmHooQ6ABG9CagdUXv2_rx
    August 25, 2021 - Dyslipidemia due to homozygous FH or secondary causes (such as diabetes, nephrotic syndrome, or hypothyroidism … Dyslipidemia due to homozygous FH or secondary causes (such as diabetes, Clinical Review & Education
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (1196)

hcup-us.ahrq.gov (1163)

effectivehealthcare.ahrq.gov (808)

www.ahrq.gov (695)

digital.ahrq.gov (428)

www.uspreventiveservicestaskforce.org (380)

cds.ahrq.gov (21)

cdsic.ahrq.gov (16)

integrationacademy.ahrq.gov (8)

meps.ahrq.gov (7)

datatools.ahrq.gov (4)

qualityindicators.ahrq.gov (4)

pso.ahrq.gov (2)